期刊文献+

重视脂肪酸氧化代谢病的筛查与诊治 被引量:14

Paying attention to screening,diagnosis and treatment of fatty acid oxidation disorders
原文传递
导出
摘要 脂肪酸氧化代谢病(fatty acid oxidation disorders,FAOD)是脂肪酸氧化代谢过程中十余种疾病的总称,均属于常染色体隐性遗传病,是常见的遗传代谢病,从新生儿至成人均可发病,临床表现无特异性,主要表现为肝病、心肌病及肌肉疾病。串联质谱检测血游离肉碱、酰基肉碱水平及基因检测是诊断此类疾病的重要方法。串联质谱新生儿筛查有助于FAOD的早诊断及早治疗。原发性肉碱缺乏症及多种酰基辅酶A脱氢酶缺乏症有特异治疗药物,效果较好,其他疾病无特异药物,需要对症治疗。 Fatty acid oxidation disorders(FAOD)include more than 10 kinds of diseases,they all belong to autosomal recessive diseases and are common inherited metabolic diseases. Onset age of the patients with FAOD are from newborn to adult. The clinical manifestations were nonspecific,mainly manifested as liver disease,cardiomyopathy and muscle diseases. Detection of free carnitine and acylcarnitines in blood by tandem mass spectrometry and detection of gene mutations are important methods for diagnosis of such diseases. Tandem mass screening for neonatal screening is helpful for early diagnosis and early treatment of FAOD. Primary carnitine deficiency and multiple acyl-CoA dehydrogenase deficiency can be treated by specific therapeutic drugs with good effect. There are no specific drugs for other diseases,which need symptomatic treatment.
作者 韩连书 HAN Lian-shu(Department of Endocrinology and Genetics of Children ,Xinhua Hospital Affiliated to Medical College of Shanghai Jiaotong University, Shanghai Institute of Pediatric Medicine ,Shanghai 200092,China)
出处 《中国实用儿科杂志》 CSCD 北大核心 2019年第1期6-10,共5页 Chinese Journal of Practical Pediatrics
基金 国家重点研发计划(2016YFC0901505) 上海市体育局科研项目(15Z028)
关键词 脂肪酸氧化代谢病 遗传代谢病 串联质谱 fatty acid oxidation disorders inherited metabolic diseases tandem mass spectrometry
  • 相关文献

参考文献3

二级参考文献26

  • 1顾学范,韩连书,高晓岚,杨艳玲,叶军,邱文娟.串联质谱技术在遗传性代谢病高危儿童筛查中的初步应用[J].中华儿科杂志,2004,42(6):401-404. 被引量:142
  • 2韩连书,高晓岚,叶军,邱文娟,顾学范.串联质谱分析干血滤纸片酰基肉碱方法的建立[J].中华检验医学杂志,2005,28(1):88-91. 被引量:31
  • 3韩连书,高晓岚,叶军,邱文娟,顾学范.串联质谱技术在有机酸血症筛查中的应用研究[J].中华儿科杂志,2005,43(5):325-330. 被引量:62
  • 4Lindner M, Gramer G, Haege G, et al. Efficacy and outcome of expanded newborn screening for metabolic diseases--report of 10 years from South-West Germany. Orphanet J Rare Dis,20! 1,6:44- 53.
  • 5Longo N, Amat di San Filippo C, Pasquali M. Disorders of carnitine transport and the carnitine cycle. Am J Med Genet C Semin Med Genet,2006,142C :77-85.
  • 6Flanagan JL, Simmons PA, Vehige J, et al. Role of carnitine in disease. Nutr Metab (Lond) ,2010,7 : 3043.
  • 7Crill CM, Helms RA. The use of carnitine in pediatric nutrition. Nutr Clin Pract ,2007,22:204-213.
  • 8Amat di San Filippo C, Pasquali M, Longo N. Pharmacological rescue of carnitinc transport in primary carnitine deficiency. Hum Murat, 2006,27 : 513 -523.
  • 9Amat di San Filippo C, Taylor MR, Mestroni L, et al.Cardiomyopathy and carnitine deficiency. Mol Genet Metab,2008, 94 : 162-166.
  • 10Yamak AA, Bitar F, Karam P, et al. Exclusive cardiac dysfunction in familial primary camitine deficiency cases: a genotype-phenotype correlation. Clin Genet, 2007,72 : 59 -62.

共引文献83

同被引文献86

引证文献14

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部